Omission of surgery, primary endocrine therapy adherence, and effect of comorbidity in older women with estrogen receptor positive breast cancer-Reference-Cited by-同舟云学术

Omission of surgery, primary endocrine therapy adherence, and effect of comorbidity in older women with estrogen receptor positive breast cancer

Published:2023-12 Issue: Volume: Page:101679
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Carleton Neil,Abidi Hira,Puthanmadhom-Narayanan Susrutha,Marroquin Oscar C.,Oesterreich Steffi,Diego Emilia J.,Brufsky Adam M.,Lee Adrian V.,McAuliffe Priscilla F.

Funder

National Cancer Institute

Breast Cancer Research Foundation

National Institutes of Health

Hillman Cancer Center, Medical Center, University of Pittsburgh

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference19 articles.

1. Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer;Morgan;Eur J Surg Oncol,2021

2. Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life;Wyld;Eur J Cancer,2021

3. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer;Fennessy;Br J Surg,2004

4. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial;Mustacchi;Ann Oncol,2003

5. Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women;Carleton;Lancet Healthy Longev,2022